COEPW icon

Coeptis Therapeutics Holdings, Inc. Warrants

0.0318 USD
At close May 15, 4:00 PM EDT
1 day
0.00%
5 days
6.35%
1 month
448.28%
3 months
38.86%
6 months
59.00%
Year to date
-11.17%
1 year
50.71%
5 years
-94.70%
10 years
-94.70%
 

About: Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Employees: 7

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

2.11% less ownership

Funds ownership: 4.47% [Q3] → 2.36% (-2.11%) [Q4]

24% less capital invested

Capital invested by funds: $27.4K [Q3] → $20.8K (-$6.61K) [Q4]

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

29% less funds holding

Funds holding: 17 [Q3] → 12 (-5) [Q4]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Research analyst outlook

We haven’t received any recent analyst ratings for COEPW.

Financial journalist opinion

We haven’t received any recent news articles for COEPW.

Charts implemented using Lightweight Charts™